FDA Approves Blueprint Medicines' AYVAKIT? (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis

?View original content to download multimedia:http://www.prnewswire.com/news-releases/fda-approves-blueprint-medicines-ayvakit-avapritinib-for-the-treatment-of-adults-with-advanced-systemic-mastocytosis-301314129.html